Which is the most immunogenic antigen of Salmonella Typhi?
Which of the following is true regarding lattice formation?
Which of the following is a superantigen?
CD8 antigen is present on which type of immune cell?
Immunoglobulins are secreted by which of the following cells?
Which of the following is not encoded by the MHC Class III region?
Which nephritogenic antigen is detected in subepithelial humps of post-streptococcal glomerulonephritis (PSGN)?
Which is the most abundant and common complement component for both the classical and alternative pathways?
Neisseria infections are associated with which of the following?
Allergic reactions are which type of hypersensitivity reaction?
Explanation: **Explanation:** The immunogenicity of an antigen is determined by its chemical complexity and size. In *Salmonella Typhi*, the **H (Flagellar) antigen** is the most immunogenic because it is composed of proteins (flagellin). Proteins are more potent triggers of the immune system compared to polysaccharides, leading to a robust antibody response. This is why H-agglutinins appear earlier and reach higher titers than O-agglutinins during a *Salmonella* infection. **Analysis of Options:** * **A & D. O Antigen (Somatic Antigen):** These are the same entity. The O antigen is a lipopolysaccharide (LPS) located on the outer membrane. While it is important for serogrouping, polysaccharides are generally less immunogenic than proteins. O-antibodies appear later and disappear sooner than H-antibodies. * **C. Vi Antigen:** This is a surface polysaccharide capsular antigen (Virulence antigen). It is poorly immunogenic and primarily functions by masking the O antigen from antibodies. Its main clinical utility is in identifying chronic carriers and for use in certain vaccines (e.g., Typhim VI). **High-Yield Clinical Pearls for NEET-PG:** * **Widal Test:** Measures antibodies against O and H antigens. A titer of **>1:160 for O** and **>1:160 for H** is usually considered significant in endemic areas. * **Sequence of Appearance:** In Enteric fever, O antibodies appear first (around the end of the 1st week), but H antibodies reach higher peaks and persist longer. * **Carrier State:** Persistent high titers of **Vi antibodies** (1:10 or more) suggest a chronic carrier state, as the bacteria continue to harbor the capsule in the gallbladder or urinary tract.
Explanation: **Explanation:** The **Lattice Hypothesis**, proposed by Marrack (1934), is the fundamental principle governing all visible antigen-antibody (Ag-Ab) reactions. It states that for a visible reaction to occur, multivalent antigens must be cross-linked by bivalent antibodies to form a large, insoluble three-dimensional network or "lattice." **Why Option C is correct:** Lattice formation is the prerequisite for both **precipitation** and **agglutination**. * In **precipitation**, the antigen is **soluble**. When it reacts with its specific antibody at the "Zone of Equivalence," they form a lattice that becomes too large to remain in solution and settles as a visible precipitate. * In **agglutination**, the antigen is **particulate** (e.g., bacteria, RBCs). The antibodies act as bridges between these particles, forming a lattice that results in visible clumping. **Why other options are incorrect:** * **Options A & B:** These are incorrect because they suggest the lattice phenomenon is exclusive to one type of reaction. While the physical state of the antigen differs (soluble vs. particulate), the underlying mechanism of cross-linking to form a lattice remains identical. * **Option D:** This is incorrect as no visible Ag-Ab reaction can occur without the formation of a lattice. **NEET-PG High-Yield Pearls:** 1. **Zone of Equivalence:** This is the specific ratio of Ag to Ab where lattice formation is maximal. 2. **Prozone Phenomenon:** False negative result due to **antibody excess**. No lattice forms because every antigenic site is saturated by a single antibody, preventing cross-linking. 3. **Postzone Phenomenon:** False negative result due to **antigen excess**. 4. **Valency:** For a lattice to form, the antigen must be multivalent and the antibody must be at least bivalent (IgG) or multivalent (IgM).
Explanation: **Explanation:** **Correct Answer: C. TSST (Toxic Shock Syndrome Toxin-1)** **Mechanism of Superantigens:** Superantigens are unique proteins that bypass the conventional antigen-processing pathway. Unlike regular antigens that bind to the antigen-binding groove of MHC II molecules, superantigens bind **externally** to the **Vβ region of T-cell receptors (TCR)** and the **MHC II** on antigen-presenting cells. This results in a non-specific, massive activation of T-cells (up to 20% of the total T-cell pool), leading to a "cytokine storm" (IL-1, IL-2, TNF-α, and IFN-γ). This systemic inflammatory response causes the clinical features of Toxic Shock Syndrome: fever, hypotension, and multi-organ failure. **Analysis of Incorrect Options:** * **A. Cholera toxin:** An A-B type enterotoxin produced by *Vibrio cholerae*. It acts by ADP-ribosylation of Gs proteins, increasing cAMP levels, leading to secretory diarrhea. * **B. Diphtheria toxin:** An A-B toxin produced by *Corynebacterium diphtheriae*. It inhibits protein synthesis by ADP-ribosylation of Elongation Factor-2 (EF-2). * **D. Vero-cytoxin (Shiga-like toxin):** Produced by EHEC (e.g., O157:H7). It inhibits the 60S ribosomal subunit, leading to cell death and Hemolytic Uremic Syndrome (HUS). **High-Yield Facts for NEET-PG:** * **Common Superantigens:** * *Staph. aureus:* TSST-1, Exfoliative toxin (Scalded Skin Syndrome), and Enterotoxins (Food poisoning). * *Strep. pyogenes:* Erythrogenic toxin (SpeA and SpeC) causing Scarlet fever. * **Key Feature:** Superantigens do **not** require processing by macrophages; they bind directly to the outside of the MHC II-TCR complex. * **Consequence:** Massive release of **TNF-α** is the primary driver of shock in these patients.
Explanation: **Explanation:** The **CD8 antigen** is a transmembrane glycoprotein that serves as a co-receptor for the T-cell receptor (TCR). It specifically recognizes and binds to **MHC Class I** molecules. **Why T suppressor cells are correct:** T lymphocytes are broadly divided into two subsets based on their surface markers. CD8+ T cells primarily differentiate into two functional types: **Cytotoxic T cells (Tc)** and **Suppressor T cells (Ts)**. While Cytotoxic T cells directly kill virally infected or tumor cells, Suppressor T cells play a crucial role in downregulating the immune response and maintaining self-tolerance. Therefore, CD8 is the hallmark marker for T suppressor cells. **Analysis of Incorrect Options:** * **A. T helper cells:** These are characterized by the **CD4** antigen, which interacts with MHC Class II molecules. * **B. B cells:** These cells do not express CD8. Their characteristic markers include **CD19, CD20, and CD21**. * **C. Macrophages:** These are professional antigen-presenting cells (APCs) that express **CD14** and MHC Class II. While they may express low levels of CD4, they do not express CD8. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic (Rule of 8):** CD4 × MHC II = 8; CD8 × MHC I = 8. * **CD4:CD8 Ratio:** In a healthy individual, the normal ratio is approximately **2:1**. This ratio is characteristically **reversed (<1)** in HIV/AIDS due to the depletion of CD4+ T cells. * **MHC Restriction:** CD8+ cells are "MHC Class I restricted," meaning they only recognize endogenous antigens presented on MHC I (found on all nucleated cells).
Explanation: **Explanation:** **Why Plasma Cells are the Correct Answer:** Immunoglobulins (antibodies) are produced and secreted exclusively by **Plasma cells**. These cells are the final functional stage of **B-lymphocyte** differentiation. When a B-cell encounters a specific antigen and receives necessary T-cell help, it undergoes clonal expansion and differentiates into plasma cells. These cells are specialized "protein factories" characterized by an extensive rough endoplasmic reticulum (RER) and a prominent Golgi apparatus, allowing them to synthesize and secrete thousands of antibody molecules per second. **Analysis of Incorrect Options:** * **A. Macrophages:** These are professional phagocytes derived from monocytes. Their primary role is engulfing pathogens and acting as **Antigen-Presenting Cells (APCs)**, not antibody production. * **C. T-cells:** These are responsible for **Cell-Mediated Immunity**. While they regulate the immune response (Helper T-cells) or kill infected cells directly (Cytotoxic T-cells), they do not secrete antibodies. * **D. Neutrophils:** These are the first responders to acute inflammation. They eliminate pathogens via phagocytosis, degranulation, and the formation of Neutrophil Extracellular Traps (NETs). **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** On histology, plasma cells exhibit a characteristic **"Cart-wheel" or "Clock-face" nucleus** and a **perinuclear halo** (representing the Golgi apparatus). * **Malignancy:** A clonal proliferation of plasma cells leads to **Multiple Myeloma**, characterized by the production of monoclonal (M) proteins. * **Russell Bodies:** These are eosinophilic inclusions found in plasma cells undergoing excessive immunoglobulin synthesis. * **B-cell Marker:** CD19, CD20, and CD21 are markers for B-cells, but mature plasma cells often lose CD20 and express **CD138**.
Explanation: The **Major Histocompatibility Complex (MHC)** is a large gene cluster on chromosome 6. While Class I and II genes encode cell surface molecules involved in antigen presentation, the **Class III region** encodes a diverse group of secreted proteins involved in the immune and inflammatory response. ### Why Complement C3 is the Correct Answer **Complement C3** is not encoded within the MHC locus. It is encoded by a gene located on **Chromosome 19**. While the MHC Class III region does encode several components of the complement system (specifically C2, C4A, C4B, and Factor B), C3 is a notable exception and a common "trap" in PG entrance exams. ### Analysis of Incorrect Options * **Properdin:** While historically some texts debated its location, modern genomic mapping confirms that genes for several alternative pathway components and inflammatory regulators are associated with the MHC III region. However, in the context of this classic MCQ, **TNF** and **HSPs** are the definitive MHC III products. * **TNF-alpha:** The genes for Tumor Necrosis Factor (TNF-α) and Lymphotoxin (TNF-β) are located within the MHC Class III region, between the Class I and Class II clusters. * **Heat Shock Proteins (HSPs):** Specifically, the **HSP70** family genes are located within the MHC Class III region. They act as molecular chaperones and are involved in protein folding and cytoprotection. ### High-Yield Clinical Pearls for NEET-PG * **MHC Location:** Short arm of **Chromosome 6 (6p)**. * **MHC Class III Products:** Remember the mnemonic **"C-T-H"**: 1. **C**omplement proteins (C2, C4, Factor B). 2. **T**umor Necrosis Factors (TNF-α, TNF-β). 3. **H**eat Shock Proteins (HSP70). * **Key Distinction:** MHC Class I and II molecules are membrane-bound, whereas MHC Class III molecules are mostly **secreted proteins** and do not participate in antigen presentation.
Explanation: **Explanation:** Post-streptococcal glomerulonephritis (PSGN) is a classic Type III hypersensitivity reaction occurring 1–3 weeks after a Group A Streptococcal (GAS) skin or throat infection. The pathogenesis involves the deposition of immune complexes in the glomerular basement membrane. **Why Option A is correct:** **Streptococcal pyrogenic exotoxin B (SpeB)** is currently considered the primary nephritogenic antigen. It is a cationic cysteine protease that has a high affinity for the glomerular basement membrane. Due to its cationic (positive) charge, it crosses the basement membrane and deposits in the subepithelial space, leading to the formation of the characteristic **"subepithelial humps"** seen on Electron Microscopy. **Why other options are incorrect:** * **Option B (NAPlr):** While Nephritis-associated plasmin receptor (NAPlr) is also a nephritogenic antigen, it is typically found early in the disease and is localized to the **mesangium and subendothelial space**, rather than the subepithelial humps. * **Option C (M antigen):** M protein is the chief virulence factor of *S. pyogenes* (antiphagocytic). While certain "nephritogenic strains" are identified by their M-protein type (e.g., Type 12 for pharyngitis, Type 49 for impetigo), the protein itself is not the primary antigen found in the humps. * **Option D (P antigen):** This is associated with Parvovirus B19 (the cellular receptor) or certain blood group systems, but has no role in the pathogenesis of PSGN. **High-Yield Clinical Pearls for NEET-PG:** * **Light Microscopy:** Enlarged, hypercellular glomeruli ("Lumpy-bumpy" appearance). * **Immunofluorescence:** "Starry sky" or granular appearance (IgG and C3 deposits). * **Electron Microscopy:** Pathognomonic **subepithelial humps**. * **Serology:** Low C3 levels (hallmark) and elevated ASO titers (after pharyngitis) or Anti-DNase B (after skin infection).
Explanation: **Explanation:** **C3** is the correct answer because it is the most abundant complement protein in human serum (concentration approx. 1.2 mg/ml) and serves as the **central convergence point** for all three complement activation pathways (Classical, Alternative, and Lectin). 1. **Why C3 is correct:** In the **Classical pathway**, the C3 convertase (C4b2a) cleaves C3. In the **Alternative pathway**, the C3 convertase (C3bBb) also cleaves C3. This step is the "amplification loop" of the complement system, where a single convertase molecule can cleave hundreds of C3 molecules into C3a (anaphylatoxin) and C3b (opsonin). 2. **Why other options are incorrect:** * **C1q:** This is the recognition unit specific only to the **Classical pathway** (binding to Fc portions of IgM or IgG). It is not involved in the Alternative pathway. * **C5:** This component is involved in the late phase (formation of the Membrane Attack Complex). While common to both pathways, it is significantly less abundant in serum than C3 and acts downstream of the C3 convergence point. * **C8:** This is a structural component of the Membrane Attack Complex (MAC). It is present in much lower concentrations and only functions at the terminal stage of the cascade. **High-Yield Clinical Pearls for NEET-PG:** * **C3 deficiency:** Associated with recurrent pyogenic infections (e.g., *S. pneumoniae*, *H. influenzae*) and Type III hypersensitivity reactions (Glomerulonephritis). * **C3b function:** Major **opsonin** (facilitates phagocytosis via CR1 receptors). * **C3a/C5a function:** **Anaphylatoxins** (trigger mast cell degranulation); C5a is also a potent chemoattractant for neutrophils. * **Most common complement deficiency:** C2 deficiency (often presents with SLE-like features).
Explanation: **Explanation:** The correct answer is **B. Deficiency of late complements**. **Why it is correct:** The late complement components (**C5, C6, C7, C8, and C9**) assemble to form the **Membrane Attack Complex (MAC)**. The MAC is essential for the lysis of Gram-negative bacteria with thin peptidoglycan layers. *Neisseria* species (*N. meningitidis* and *N. gonorrhoeae*) are uniquely susceptible to MAC-mediated killing. Patients with deficiencies in these terminal components cannot form the MAC effectively, leading to a significantly increased risk (up to 10,000-fold) of recurrent disseminated Neisserial infections. **Why other options are incorrect:** * **Option A:** Deficiency of **early complements** (C1, C2, C4) is primarily associated with **immune complex diseases** like Systemic Lupus Erythematosus (SLE) and pyogenic infections (e.g., *S. pneumoniae*), as they are required for opsonization and clearance of immune complexes. * **Option C:** There is a well-documented clinical association between complement pathways and specific bacterial vulnerabilities. * **Option D:** While C3 deficiency is severe and increases risk for many infections, the specific, classic association for *Neisseria* is specifically with the terminal/late components. **High-Yield Clinical Pearls for NEET-PG:** * **C3 Deficiency:** The most severe complement deficiency; leads to recurrent infections with pyogenic (encapsulated) bacteria and Type III hypersensitivity reactions. * **C1 Esterase Inhibitor Deficiency:** Causes **Hereditary Angioedema** (characterized by low C4 levels). * **CH50 Assay:** Used to screen for classical pathway deficiencies; it will be low/zero in terminal component deficiencies. * **Properdin/Factor D Deficiency:** Associated with *Neisseria* due to impairment of the alternative pathway.
Explanation: **Explanation:** **Type I Hypersensitivity** (Immediate/Anaphylactic) is the correct answer. It is mediated by **IgE antibodies** that bind to the surface of mast cells and basophils. Upon re-exposure to an allergen (e.g., pollen, bee sting, or peanuts), the allergen cross-links the IgE, triggering degranulation and the release of vasoactive amines like **histamine**. This results in classic allergic symptoms ranging from hay fever and urticaria to life-threatening anaphylaxis. **Why other options are incorrect:** * **Type II (Cytotoxic):** Mediated by IgG or IgM antibodies directed against antigens on specific cell surfaces or tissues (e.g., ABO incompatibility, Rh incompatibility, or Myasthenia Gravis). * **Type III (Immune-Complex):** Caused by the deposition of antigen-antibody complexes in tissues, leading to complement activation and inflammation (e.g., SLE, Post-streptococcal glomerulonephritis, or Serum Sickness). * **Type IV (Delayed-type):** This is **cell-mediated** (T-cells), not antibody-mediated. It takes 48–72 hours to manifest (e.g., Mantoux test, contact dermatitis, or Graft-versus-host disease). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic (ACID):** **A**naphyalctic (I), **C**ytotoxic (II), **I**mmune-complex (III), **D**elayed (IV). * **Key Cells:** Mast cells are the primary effectors in Type I; T-lymphocytes/Macrophages in Type IV. * **Type I Phases:** Initial rapid response (histamine) occurs within minutes; the late-phase response (leukotrienes) occurs 2–8 hours later. * **Common Example:** Bronchial asthma is a classic Type I reaction.
Cells and Organs of Immune System
Practice Questions
Innate Immunity
Practice Questions
Adaptive Immunity
Practice Questions
Antigens and Antibodies
Practice Questions
Major Histocompatibility Complex
Practice Questions
Complement System
Practice Questions
Cytokines and Chemokines
Practice Questions
Hypersensitivity Reactions
Practice Questions
Autoimmunity and Autoimmune Diseases
Practice Questions
Immunodeficiency Disorders
Practice Questions
Transplantation Immunology
Practice Questions
Tumor Immunology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free